Consumer Defensive
Kenvue Inc.(KVUE)
Live Price
Offline$18.12
+0.61% today
1Y Change
-14.41%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $33.37B
- Revenue Growth
- -2.1%
- EPS Growth
- +42.6%
- Dividend Yield
- 4.8%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Kenvue Inc. (KVUE) is a Consumer Defensive stock with a market cap of $33.37B and listed on NYSE. The stock last traded around $18.12 and down 14.4% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of -2.1%, EPS growth of +42.6%, a dividend yield of 4.8%. What stands out right now is revenue -2.1%, EPS +42.6%, free cash flow +29.0% with operating margin 17.9% and ROIC 8.8%. The dividend matters to the case here, with a current yield around 4.8%. Valuation is more restrained than many high-expectation growth names at P/E 22.7 and price/sales 2.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines KVUE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-2.1% vs +1.7% peer median
Operating Margin
Above sector median
+17.9% vs +6.6% peer median
P/E
Above sector median
22.7 vs 14.0 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -2.1% and EPS is at +42.6%, with operating margin around 17.9%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 4.8%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +2.9% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | -0.5% | +1.6% | +5.5% |
2026 Feb 17, 2026 | +21.2% | +2.6% | +3.3% | -3.5% |
2025 Nov 3, 2025 | +7.6% | -1.1% | +3.9% | +4.5% |
Benchmark Edge
KVUE vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
KVUE
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
KVUE Max Drawdown
-38.22%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for KVUE and SPY.
Company Overview
Kenvue Inc.
New York Stock Exchange
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
- Leadership
- Kirk L. Perry
- IPO Date
- May 4, 2023
- Employees
- 22.0k
- Street Address
- 1 Kenvue Way
- Mailing
- Summit, NJ, 07901
- Region
- Summit, NJ, US
- Reporting Currency
- USD
- Investor Line
- 908 874 1200
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 22.7
- EV/EBITDA
- 13.8
- Price/Sales
- 2.2
- Price/Book
- 3.1
Growth
- Revenue
- -2.1%
- EPS
- +42.6%
- Free Cash Flow
- +29.0%
Profitability
- Gross Margin
- 58.1%
- Operating Margin
- 17.9%
- Net Margin
- 9.7%
- ROE
- 13.9%
- ROIC
- 8.8%
Balance Sheet
- Debt/Equity
- 0.79
- Current Ratio
- 0.96
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.